171 / 1631
Cumulative incidence of breast cancer among female HL survivors by
RT field, prescribed dose and duration of intact ovarian function
174 BC cases and 466 controls nested in cohort of 3905 5-yr HL survivors
treated 1965-2000
Conclusion:
•
Hormone replacement therapy does not
appear to increase BC risk for HL survivors
with therapy-induced early menopause.
Krul et al, IJROBP 2017